19 March 2024 | A courtesy visit and meeting session between Universiti Teknologi MARA and Pfizer was held on the 19th of March 2024 at Bangunan Canseleri Tuanku Syed Sirajuddin, UiTM Shah Alam.

This significant gathering is a testament to the strength of our partnership and the commitment of both Pfizer and UiTM to drive positive change through collaborative research and innovation.

Some of UiTM’s esteemed researchers have worked with Pfizer over the past years, engaging in various activities. This shows that dedication, expertise, and passion are the driving forces behind our shared vision.

Prof. Ts. Dr. Norazah Abdul Rahman, Deputy Vice-Chancellor (Research & Innovation), said during her welcoming speech that UiTM has the power to make a profound and lasting impact on the world and is confident that, with collective efforts, UiTM will continue to achieve great things.

The primary objective of this meeting is to discuss potential collaborations of UiTM in areas including but not limited to Antimicrobial Resistance, Rare Diseases, and Mental Health.

Earlier, the Pfizer team had the opportunity to meet and greet Prof. Datuk Shahrin @ Sahib Sahibuddin, Vice-Chancellor of UiTM, at his office.

We hope this collaboration continues to thrive and prosper in the years to come.

Any proposals that align with Pfizer’s areas of interest can be submitted through this link: https://www.pfizer.com/about/programs-policies/grants

UiTM was represented by Prof. Ts. Dr. Norazah Abdul Rahman, Senior Management of Office of Deputy Vice-Chancellor (Research & Innovation), Head of Deputy Registrar, Directors of Center of Excellence (CoE), Assistant Vice-Chancellor, and Deans.

The Pfizer delegation was represented by Mr. Hiroaki Tsukada, Senior Director, Global Policy and Public Affairs, Asia Pacific Lead, Mdm. Deborah Seifert, Malaysia Indonesia/Singapore/Philippines Cluster Lead, Mrs. Shamie Zainal, Director, Global Policy and Public Affairs, Malaysia/Indonesia/Singapore/Philippines/Pakistan Lead, Mr. Saif Arman, Health & Social Impact Manager, Ms. Adeline Anpanandan – Policy & Public Affairs – Protégé, and Ms. Adiba Najwa – Corporate Affairs – Protégé.